Leerink Partners Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $2
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
Leerink Partners analyst Roanna Ruiz initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price Target of $2.
Leerink Partners analyst Roanna Ruiz initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price Target of $2.